Thank you, Simon and good morning to our investors, analysts and employees. I will discuss our second quarter financial results, both on a consolidated basis as well as by business segment. Net sales for the second quarter of 2015 were $92 million. This is compared to $84.4 million in Q2 last year representing a 9% increase on a consolidated basis. Sales for our Lifeboat Distribution segment were $81.3 million and represent 88% of our total revenue during the quarter. Lifeboat sales reflect a 16% increase compared to the prior year. This increase in sales in the Lifeboat segment was mainly a result of the addition of several key product lines and strengthening of our account penetration. Sales for our TechXtend segment were $10.7 million compared to $14.4 million in the prior year, representing a 26% decrease. The decrease in net sales in the TechXtend segment was primarily due to both a decrease in extended payment term sales transactions and larger sales transactions as compared to the prior year. On a consolidated basis, our gross profit was $6.4 million compared to $6.1 million for the second quarter of 2014, representing a 5% increase. Our gross profit margin for the quarter was 7% compared to 7.3% in Q2 last year. Lifeboat Distribution’s gross profit for the quarter was $5.1 million. This compared to $4.6 million in Q2 last year, representing an 11% increase. This increase was primarily due to higher sales volume in the current year. Our TechXtend segment’s gross profit was $1.3 million and decreased by 14% compared to last year. The decrease in gross margin for our TechXtend segment was due to lower sales volume. Total selling, general and administrative expenses were $4.4 million compared to $4 million in the prior year. This increase is primarily the result of an increase in sales-related employee and employee-related expenses, salaries, commissions, bonuses and benefits in 2015 compared to the prior year. A large part of this increase is due to us hiring the field sales team and a professional service team. We expect these investments to support and accelerate future sales and gross margin growth. Our net income for the quarter was $1.4 million compared to $1.5 million in the prior year. Earnings per share on a fully diluted basis were $0.29 per share compared to $0.31 in the prior year. Now, moving on to the balance sheet, compared to our year end balance sheet, the following key accounts had fluctuations. Cash was a healthy $18.9 million at the end of the quarter compared to $23.1 million at December 31. This decrease is primarily composed of stock purchases of $2.8 million and dividend payments of $1.6 million. Accounts receivable, current and long-term, decreased by 10%. This decrease is primarily due to a lower level of sales as compared to the fourth quarter of 2014 and fewer extended payment term transactions in 2015 as compared to 2014. Accounts payable and accrued expenses decreased by 16% due to lower sales volume compared to the prior year and an increase in early payment discounts taken by the company in the current year. The company has no debt. We do however have a $10 million revolving credit facility that can be used for working capital purposes, including financing of larger extended payment term sales transactions. At the end of the quarter, we have no outstanding debt balance under the credit facility. Working capital at the end of the quarter was $32.4 million. During the quarter, we have repurchased approximately 13,000 shares of our common stock. We still have authorization to buyback approximately 549,000 shares. Our stockholders’ equity now stands at $38.6 million. At our July 29, 2015, Board of Directors meeting, the Board declared a dividend of $0.17 per share for its common stock payable August 17 to shareholders of record on August 10. In conclusion, the company continues to have solid operating results, a strong balance sheet and is adequately capitalized to support our future growth plan. Simon, I will turn it back to you.